Olga Zlobinskaya

Olga Zlobinskaya has extensive work experience in various roles within the pharmaceutical and research industries. Olga currently holds the position of Clinical Study Lead at Immunic Therapeutics, where they started in August 2021 as an Associate Clinical Project Manager before being promoted to Associate Clinical Study Lead. Prior to that, they worked at Covance as a CRA II from March 2018 to June 2021 and as a CRA I MEA from September 2016 to March 2018. Olga also gained experience as an Assistant Sales and Project Management at vivoPharm Pty Ltd from September 2014 to September 2016. Olga has academic research experience as an Independent Postdoc Researcher at Klinikum Rechts der Isar, Technische Universität München, from September 2013 to September 2014, and as a Research Assistant and Postdoc at the same institution from September 2008 to July 2012. Olga's earlier research positions include being a Postdoctoral Research Scientist at the University of Graz, Institute of Molecular Biosciences, from March 2006 to August 2008, a Postdoctoral Research Fellow at IGBMC from 2004 to 2006, and a Postdoctoral Researcher at klinikum Mannheim GmbH, Zentrum für Medizinische Forschung, from January 2003 to February 2005.

Olga Zlobinskaya pursued their education in Molekular Biologie, earning a Ph.D. degree (Dr. Sc. hum) from Heidelberg University between 2000 and 2003.